WallStreetZenWallStreetZen

NASDAQ: BJDX
Bluejay Diagnostics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Bluejay Diagnostics earnings were -$6.8M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest BJDX earnings report on Dec 31, 2025 announced Q4 2025 earnings of -$1.4M, down 10.5% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, BJDX reported annual earnings of -$6.8M, with -67.3% growth.

BJDX earnings history

Current Revenue
$0.0
Current Earnings
-$6.8M
Current Profit Margin
0%

BJDX Return on Equity

Current Company
-145.5%
Current Industry
8.8%
Current Market
28.9%
BJDX's Return on Equity (-145.5%)... subscribe to Premium to read more.
High Return on Equity Performance

BJDX Return on Assets

Current Company
-115.6%
Current Industry
5.4%
BJDX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when BJDX announces earnings.

BJDX Return on Capital Employed

Current Company
-114.13%
Current Industry
9.4%
BJDX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BJDX vs Medical Device Stocks

TickerEBITDAEarningsY/Y EarningsEPS
BJDX-$6.68M-$6.85MN/A-$15.25
VTAK-$13.12M-$22.19M+97.86%$33.30
BBLG-$3.11M-$3.11MN/A-$2.65
NUWE-$6.55M-$17.52MN/A-$25.39
IVF-$27.33M-$29.21MN/A-$3,327.80
View Top Medical Device Stocks

Bluejay Diagnostics Earnings Reports & History FAQ

What were Bluejay Diagnostics's earnings last quarter?

Bluejay Diagnostics (NASDAQ: BJDX) reported Q4 2025 earnings per share (EPS) of $3.25, up 99.52% year over year. Total BJDX earnings for the quarter were -$1.43 million. In the same quarter last year, Bluejay Diagnostics's earnings per share (EPS) was $676.25.

If you're new to stock investing, here's how to buy Bluejay Diagnostics stock.

Is Bluejay Diagnostics profitable or losing money?

As of the last Bluejay Diagnostics earnings report, Bluejay Diagnostics is currently losing money. Bluejay Diagnostics's net profit (also called net income) for the twelve months ending Dec 31, 2025 was -$6.85 million, a 11.26% decrease year over year.

What was BJDX's earnings growth in the past year?

As of Bluejay Diagnostics's earnings date in Q2 2026, Bluejay Diagnostics's earnings has grown year over year. BJDX earnings in the past year totalled -$6.85 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.